[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Citations 0
Correction
June 13, 2001

Wording and Level Errors

JAMA. 2001;285(22):2858. doi:10.1001/jama.285.22.2858

In the Original Contribution entitled "Abacavir-Lamivudine-Zidovudine vs Indinavir-Lamivudine-Zidovudine in Antiretroviral-Naive HIV-Infected Adults: A Randomized Equivalence Trial" published in the March 7, 2001, issue of THE JOURNAL (2001;285:1155-1163), wording and level errors appeared. On page 1158, the last sentence in the first paragraph in column 3 should be: "In the as-treated analysis, the proportion of patients who had HIV RNA levels of 50 copies/mL or less was greater in the indinavir-lamivudine-zidovudine group for both strata: 76% (74/97) vs 88% (76/86) with a treatment difference of − 12% (95% CI, − 23% to − 1%) for the low baseline HIV RNA stratum and 57% (30/53) vs 74% (45/61) with a treatment difference of − 17% (95% CI, − 34% to 0%) for the high baseline HIV RNA stratum." On page 1162, the last sentence in the first full paragraph should be: "The difficulty in achieving an undetectable viral load among patients with high baseline HIV-1 RNA levels supports the need to initiate antiretroviral treatment in a manner consistent with treatment guidelines.1,2"

×